Risk of adverse events after Omicron XBB-adapted BNT162b2 COVID-19 vaccination in the United States. Sun JW, Dodge LE, Kim EJ, Zhou L, et al. Vaccine 2024;45:126629.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Sun JW, Dodge LE, Kim EJ, Zhou L, et al. Risk of adverse events after Omicron XBB-adapted BNT162b2 COVID-19 vaccination in the United States. Vaccine 2024;45:126629.
PMID: 39700907